IPA Announces $10.0 Million Bought Deal Offering of Common Shares

IMMUNOPRECISE ANTIBODIES LTD. (the „Company“ or „IPA“) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic …

IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic ...